These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15708672)

  • 21. Model-based multiplicity estimation of population size.
    Laska EM; Meisner M; Wanderling J
    Stat Med; 2009 Jul; 28(17):2230-52. PubMed ID: 19572380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effective number of subjects and number of raters for inter-rater reliability studies.
    Saito Y; Sozu T; Hamada C; Yoshimura I
    Stat Med; 2006 May; 25(9):1547-60. PubMed ID: 16143966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reproducibility and imputation of air toxics data.
    Le HQ; Batterman SA; Wahl RL
    J Environ Monit; 2007 Dec; 9(12):1358-72. PubMed ID: 18049775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonparametric inference on the E/O ratio in model validation.
    Qu Y; Wang Y
    Stat Med; 2008 Jul; 27(17):3340-9. PubMed ID: 18076129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determining the error of dose estimates and minimum and maximum acceptable concentrations from assays with nonlinear dose-response curves.
    Gottschalk PG; Dunn JR
    Comput Methods Programs Biomed; 2005 Dec; 80(3):204-15. PubMed ID: 16256244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CHROMATOGRAPHIC TECHNIQUES IN PHARMACEUTICAL ANALYSIS IN POIAND: HISTORY AND THE PRESENCE ON THE BASIS OF PAPERS PUBLISHED IN SELECTED POLISH PHARMACEUTICAL JOURNALS IN XX CENTURY.
    Bilek M; Namieśnik J
    Acta Pol Pharm; 2016; 73(3):605-12. PubMed ID: 27476277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An isocratic ion exchange HPLC method for the simultaneous determination of flucloxacillin and amoxicillin in a pharmaceutical formulation for injection.
    Liu H; Wang H; Sunderland VB
    J Pharm Biomed Anal; 2005 Feb; 37(2):395-8. PubMed ID: 15708684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Analysis and importance of statistical power and sample size in empirical scientific research].
    Klimek KM
    Wiad Lek; 2008; 61(7-9):211-5. PubMed ID: 19172834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sample size for FDR-control in microarray data analysis.
    Jung SH
    Bioinformatics; 2005 Jul; 21(14):3097-104. PubMed ID: 15845654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of suitable sample sizes for multi-patient based finite element studies.
    Radcliffe IA; Prescott P; Man HS; Taylor M
    Med Eng Phys; 2007 Dec; 29(10):1065-72. PubMed ID: 17218146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequential analysis of latent variables using mixed-effect latent variable models: Impact of non-informative and informative missing data.
    Sébille V; Hardouin JB; Mesbah M
    Stat Med; 2007 Nov; 26(27):4889-904. PubMed ID: 17576119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correction for regression dilution bias using replicates from subjects with extreme first measurements.
    Berglund L; Garmo H; Lindbäck J; Zethelius B
    Stat Med; 2007 May; 26(10):2246-57. PubMed ID: 16969892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. European ring exercise on water toxicity using different bioluminescence inhibition tests based on Vibrio fischeri, in support to the implementation of the water framework directive.
    Farré M; Martínez E; Hernando MD; Fernández-Alba A; Fritz J; Unruh E; Mihail O; Sakkas V; Morbey A; Albanis T; Brito F; Hansen PD; Barceló D
    Talanta; 2006 Apr; 69(2):323-33. PubMed ID: 18970570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sample size calculation for the Power Model for dose proportionality studies.
    Sethuraman VS; Leonov S; Squassante L; Mitchell TR; Hale MD
    Pharm Stat; 2007; 6(1):35-41. PubMed ID: 17323313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Broad range analysis of endocrine disruptors and pharmaceuticals using gas chromatography and liquid chromatography tandem mass spectrometry.
    Trenholm RA; Vanderford BJ; Holady JC; Rexing DJ; Snyder SA
    Chemosphere; 2006 Dec; 65(11):1990-8. PubMed ID: 16949633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A simulation study with statistical evaluation for the determination of non-isothermal kinetics conditions in drugs stability.
    Fernández de Aránguiz MY; de la Torre S; Berraondo MR
    Eur J Pharm Sci; 2007 Aug; 31(5):277-87. PubMed ID: 17540544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statistical issues in the use of the comet assay.
    Lovell DP; Omori T
    Mutagenesis; 2008 May; 23(3):171-82. PubMed ID: 18385511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A latent-class mixture model for incomplete longitudinal Gaussian data.
    Beunckens C; Molenberghs G; Verbeke G; Mallinckrodt C
    Biometrics; 2008 Mar; 64(1):96-105. PubMed ID: 17608789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simple assessment of homogeneity in pharmaceutical mixing processes using a near-infrared reflectance probe and control charts.
    Skibsted ET; Boelens HF; Westerhuis JA; Witte DT; Smilde AK
    J Pharm Biomed Anal; 2006 Apr; 41(1):26-35. PubMed ID: 16289623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimal spending functions for asymmetric group sequential designs.
    Anderson KM
    Biom J; 2007 Jun; 49(3):337-45. PubMed ID: 17623339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.